70
Views
58
CrossRef citations to date
0
Altmetric
Articles

The Increase in Carbapenem Use and Emergence of Stenotrophomonas maltophilia as an Important Nosocomial Pathogen

Pages 28-33 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Gokhan Metan, Mutlu Hayran, Gulsen Hascelik & Omrum Uzun. (2006) Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scandinavian Journal of Infectious Diseases 38:6-7, pages 527-531.
Read now
G. Gattuso, D. Tomasoni, R. Ceruti & A. Scalzini. (2004) Multiresistant Stenotrophomonas maltophilia Tunneled CVC-Related Sepsis, Treated with Systemic and Lock Therapy. Journal of Chemotherapy 16:5, pages 494-496.
Read now
M. Babálová, J. Blahová, K. Králiková, V. Krčméry & K. Kuboňová. (2002) Nosocomial Stenotrophomonas maltophilia Strain with a Broad Host Range Ability to Transfer Antibiotic Resistance. Journal of Chemotherapy 14:6, pages 639-639.
Read now
Joan Fung-Tomc & Oak K Kim. (2001) Patents on β-lactam antibacterials: January 1999 to March 2001. Expert Opinion on Therapeutic Patents 11:8, pages 1267-1276.
Read now

Articles from other publishers (54)

George Dimopoulos, José Garnacho-Montero, Elisabeth Paramythiotou, Antonio Gutierrez-Pizarraya, Charalambos Gogos, Maria Adriansen-Pérez, Chrysa Diakaki, Dimitrios K. Matthaiou, Garyphalia Poulakou & Karolina Akinosoglou. (2023) Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?. Diagnostics 13:6, pages 1106.
Crossref
Annika Belzer, Emma Weiss, Farshid Etaee, Christopher Bunick, William Damsky & Caroline Nelson. (2022) Stenotrophomonas maltophilia, a Pathogen of Increasing Relevance to Dermatologists: A Case Report and Review of the Literature. Antibiotics 11:10, pages 1398.
Crossref
Stefan K. Zöllner, Stefanie Kampmeier, Neele J. Froböse, Heidrun Herbrüggen, Katja Masjosthusmann, Alijda van den Heuvel, Christian Reicherts, Andreas Ranft & Andreas H. Groll. (2021) Stenotrophomonas maltophilia Infections in Pediatric Patients – Experience at a European Center for Pediatric Hematology and Oncology. Frontiers in Oncology 11.
Crossref
Eun Jin Kim, Yong Chan Kim, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Jun Yong Choi, Joon-Sup Yeom & Young Goo Song. (2019) Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone–resistant strains. BMC Infectious Diseases 19:1.
Crossref
Geraint Rogers & Yvonne J. Huang. 2019. The Lung Microbiome. The Lung Microbiome 158 172 .
Kenneth V. I. Rolston & Amar Safdar. 2019. Principles and Practice of Transplant Infectious Diseases. Principles and Practice of Transplant Infectious Diseases 461 472 .
Geraint B. Rogers. 2018. Bronchiectasis. Bronchiectasis 82 98 .
Oleg Stens, Gabriel Wardi, Matthew Kinney, Stephanie Shin & Demosthenes Papamatheakis. (2018) Stenotrophomonas maltophilia Necrotizing Soft Tissue Infection in an Immunocompromised Patient . Case Reports in Critical Care 2018, pages 1-5.
Crossref
Janos Cambiaso-Daniel, James J. Gallagher, William B. Norbury, Celeste C. Finnerty, David N. Herndon & Derek M. Culnan. 2018. Total Burn Care. Total Burn Care 93 113.e4 .
Soumya Mukherjee, Bassel Zebian, Chris Chandler & Benedetta Pettorini. (2017) Stenotrophomonas maltophilia CSF infection in infants after neurosurgery . British Journal of Hospital Medicine 78:12, pages 724-725.
Crossref
Ibrahim A. Janahi & Abdul Rehman. 2017. Progress in Understanding Cystic Fibrosis. Progress in Understanding Cystic Fibrosis.
Hirotaka Ebara, Hideharu Hagiya, Yuto Haruki, Eisei Kondo & Fumio Otsuka. (2017) Clinical Characteristics of <i>Stenotrophomonas maltophilia</i> Bacteremia: A Regional Report and a Review of a Japanese Case Series. Internal Medicine 56:2, pages 137-142.
Crossref
Ji-Yong Lee, Cheol-In Kang, Jae-Hoon Ko, Woo Joo Lee, Hye-Ri Seok, Ga Eun Park, Sun Young Cho, Young Eun Ha, Doo Ryeon Chung, Nam Yong Lee, Kyong Ran Peck & Jae-Hoon Song. (2016) Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy. Antimicrobial Agents and Chemotherapy 60:11, pages 6673-6678.
Crossref
Ciji Arthur, Xinyu Tang, Jose R. Romero, Jeffrey G. Gossett, Nada Harik & Parthak Prodhan. (2014) Stenotrophomonas maltophilia Infection Among Young Children in a Cardiac Intensive Care Unit: A Single Institution Experience. Pediatric Cardiology 36:3, pages 509-515.
Crossref
Kenneth V. I. Rolston. 2015. Infections in Hematology. Infections in Hematology 3 23 .
Chih-Chao Yang, Chien-Hsing Wu, Chien-Te Lee, Han-Tsung Liu, Jin-Bor Chen, Chien-Hua Chiu, Chih-Hung Chen & Feng-Rong Chuang. (2014) Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy. International Journal of Infectious Diseases 28, pages 3-7.
Crossref
Chih-Chao Yang, Shau-Hsuan Li, Feng-Rong Chuang, Chih-Hung Chen, Chih-Hsiung Lee, Jin-Bor Chen, Chien-Hsing Wu & Chien-Te Lee. (2012) Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniaein patients on maintenance hemodialysis. BMC Infectious Diseases 12:1.
Crossref
M. Dryden, K. Saeed, R. Townsend, C. Winnard, S. Bourne, N. Parker, J. Coia, B. Jones, W. Lawson, P. Wade, P. Howard & S. Marshall. (2012) Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. Journal of Antimicrobial Chemotherapy 67:9, pages 2289-2296.
Crossref
Paul P. Cook, Michael Gooch & Shemra Rizzo. (2011) Reduction in Fluoroquinolone Use following Introduction of Ertapenem into a Hospital Formulary Is Associated with Improvement in Susceptibility of Pseudomonas aeruginosa to Group 2 Carbapenems: a 10-Year Study. Antimicrobial Agents and Chemotherapy 55:12, pages 5597-5601.
Crossref
Z.-B. Wu, S.-M. Pan, J. Yu, Y. Liu, X.-F. Yang & Q.-Q. Chen. (2011) Use of the DiversiLab repetitive sequence-based polymerase chain reaction system for genotyping Stenotrophomonas maltophilia isolates in different wards of one hospital. Journal of Hospital Infection 79:2, pages 180-182.
Crossref
Atef M. Diab & Idriss M. Al-Turk. (2011) ERIC and RAPD PCR-based DNA fingerprinting techniques application for microbial source tracking (MST) at Al-Madinah Al-Munwwarah, KSA. Journal of Taibah University for Science 5, pages 31-38.
Crossref
Kenneth V. I. Rolston, David E. Greenberg & Amar Safdar. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases 423 433 .
M. Yeshurun, A. Gafter-Gvili, M. Thaler, N. Keller, A. Nagler & A. Shimoni. (2010) Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience. Infection 38:3, pages 211-215.
Crossref
John J. LiPuma. (2010) The Changing Microbial Epidemiology in Cystic Fibrosis. Clinical Microbiology Reviews 23:2, pages 299-323.
Crossref
Matthew E. Falagas, Politimi-Eleni Valkimadi, Yu-Tsung Huang, Dimitrios K. Matthaiou & Po-Ren Hsueh. (2008) Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. Journal of Antimicrobial Chemotherapy 62:5, pages 889-894.
Crossref
Mucahit Yemisen, Bilgul Mete, Yusuf Tunali, Ercument Yentur & Recep Ozturk. (2008) A meningitis case due to Stenotrophomonas maltophilia and review of the literature. International Journal of Infectious Diseases 12:6, pages e125-e127.
Crossref
Jorge G. Paez, Anna S. Levin, Mariusa Basso, Laura B. Gomez, Satiko Gobara, Fernanda Spadão, Isabel Oshiro & Silvia Figueiredo Costa. (2015) Trends in Stenotrophomonas maltophilia Bloodstream Infection in Relation to Usage Density of Cephalosporins and Carbapenems During 7 Years . Infection Control & Hospital Epidemiology 29:10, pages 989-990.
Crossref
Stephanie J. Dancer. 2008. Antibiotic Policies: Fighting Resistance. Antibiotic Policies: Fighting Resistance 1 15 .
A. Safdar & K. V. Rolston. (2007) Stenotrophomonas maltophilia: Changing Spectrum of a Serious Bacterial Pathogen in Patients with Cancer. Clinical Infectious Diseases 45:12, pages 1602-1609.
Crossref
Shoaib R. Ansari, Hend Hanna, Ray Hachem, Ying Jiang, Kenneth Rolston & Issam Raad. (2007) Risk factors for infections with multidrug‐resistant Stenotrophomonas maltophilia in patients with cancer . Cancer 109:12, pages 2615-2622.
Crossref
Dag Torfoss, E. Arne Høiby, Jon Magnus Tangen, Harald Holte, Kåre Bø, Peter Meyer, Kjell Grøttum, Kjetil Weyde, Grete Fossum Lauritzsen, Berit Sandstad, Anne-Birgitte Jacobsen, Harald Olsen & Stein Kvaløy. (2007) Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial. Journal of Antimicrobial Chemotherapy 59:4, pages 711-717.
Crossref
Diego Lopez Mendoza, Michael Darin, Grant W. Waterer & Richard G. Wunderink. (2007) Update on Stenotrophomonas maltophilia Infection in the ICU. Clinical Pulmonary Medicine 14:1, pages 17-22.
Crossref
E. Meyer, F. Schwab, P. Gastmeier, H. Rüden & F. D. Daschner. (2006) Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units?. European Journal of Clinical Microbiology & Infectious Diseases 25:11, pages 711-714.
Crossref
E. Meyer, F. Schwab, P. Gastmeier, H. Rueden, F.D. Daschner & D. Jonas. (2006) Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). Journal of Hospital Infection 64:3, pages 238-243.
Crossref
Jan Patterson, Nina Clark, John Quinn & Joseph Lynch. 2005. Severe Pneumonia. Severe Pneumonia 191 273 .
Stephanie J. Dancer. 2005. Antibiotic Policies. Antibiotic Policies 281 309 .
Chih-Chao Yang, Feng-Rong Chuang, Kuo-Tai Hsu, Jin-Bor Chen, Chih-Hsiung Lee, Chie-Te Lee, Yu-Shu Chien, Te-Chuan Chen & Ben-Chung Cheng. (2004) Expanded-spectrum β-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis. American Journal of Kidney Diseases 44:6, pages e102-e106.
Crossref
Stephanie J Dancer. (2004) How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. The Lancet Infectious Diseases 4:10, pages 611-619.
Crossref
Konstantina Tzanetou, Georgios Triantaphillis, Dimitrios Tsoutsos, Dimitra Petropoulou, Georgios Ganteris, Eleni Malamou–Lada & Panos Ziroyiannis. (2020) Stenotrophomonas Maltophilia Peritonitis in CAPD Patients: Susceptibility to Antibiotics and Treatment Outcome: A Report of Five Cases. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 24:4, pages 401-404.
Crossref
E Senol. (2004) Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen. Journal of Hospital Infection 57:1, pages 1-7.
Crossref
Maria Dalamaga, Konstantinos Karmaniolas, Charilaos Chavelas, Stavros Liatis, Helen Matekovits & Ilias Migdalis. (2003) Stenotrophomonas maltophilia: a serious and rare complication in patients suffering from burns. Burns 29:7, pages 711-713.
Crossref
Ronald L. Gibson, Jane L. Burns & Bonnie W. Ramsey. (2003) Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine 168:8, pages 918-951.
Crossref
Nina M. Clark, Jan Patterson & Joseph P. Lynch,IIIIII. (2003) Antimicrobial resistance among gram-negative organisms in the intensive care unit. Current Opinion in Critical Care 9:5, pages 413-423.
Crossref
Anucha Apisarnthanarak, Jennie L. Mayfield, Teresa Garison, Patricia M. McLendon, John F. DiPersio, Victoria J. Fraser & Louis B. Polish. (2015) Risk Factors For Stenotrophomonas Maltophilia Bacteremia In Oncology Patients: A Case–Control Study . Infection Control & Hospital Epidemiology 24:4, pages 269-274.
Crossref
Paola Sandra Mercuri, Yoshikazu Ishii, Ling Ma, Gian Maria Rossolini, Francesco Luzzaro, Gianfranco Amicosante, Nicola Franceschini, Jean-Marie Frere & Moreno Galleni. (2002) Clonal Diversity and Metallo- β -Lactamase Production in Clinical Isolates of Stenotrophomonas maltophilia . Microbial Drug Resistance 8:3, pages 193-200.
Crossref
Scott D. Hanes, Kutay Demirkan, Elizabeth Tolley, Bradley A. Boucher, Martin A. Croce, G. Christopher Wood & Timothy C. Fabian. (2002) Risk Factors for Late‐Onset Nosocomial Pneumonia Caused by Stenotrophomonas maltophilia in Critically Ill Trauma Patients . Clinical Infectious Diseases 35:3, pages 228-235.
Crossref
Rahmet Caylan, Kemalettin Aydin & Iftihar Koksal. (2002) Meningitis Caused by Stenotrophomonas Maltophilia : Case Report and Review of the Literature . Annals of Saudi Medicine 22:3-4, pages 216-218.
Crossref
A. C. Gales, R. N. Jones, K. R. Forward, J. Liñares, H. S. Sader & J. Verhoef. (2001) Emerging Importance of Multidrug‐Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999) . Clinical Infectious Diseases 32:s2, pages S104-S113.
Crossref
Matthew B. Avison, Catherine S. Higgins, Charlotte J. von Heldreich, Peter M. Bennett & Timothy R. Walsh. (2001) Plasmid Location and Molecular Heterogeneity of the L1 and L2 β-Lactamase Genes of Stenotrophomonas maltophilia . Antimicrobial Agents and Chemotherapy 45:2, pages 413-419.
Crossref
Patricia Winokur, Carol E. Chenoweth, Louis Rice, Borna Mehrad & Joseph P. Lynch. 2001. Ventilator-Associated Pneumonia. Ventilator-Associated Pneumonia 131 164 .
Burke A. Cunha. (2000) ANTIBIOTIC RESISTANCE. Medical Clinics of North America 84:6, pages 1407-1429.
Crossref
David M Livermore & Neil Woodford. (2000) Carbapenemases: a problem in waiting?. Current Opinion in Microbiology 3:5, pages 489-495.
Crossref
Alessandra Micozzi, Mario Venditti, Monica Monaco, Alexander Friedrich, Fabrizio Taglietti, Stefania Santilli & Pietro Martino. (2000) Bacteremia Due to Stenotrophomonas maltophilia in Patients with Hematologic Malignancies. Clinical Infectious Diseases 31:3, pages 705-711.
Crossref
Lenore E. Asbel & Matthew E. Levison. (2000) CEPHALOSPORINS, CARBAPENEMS, AND MONOBACTAMS. Infectious Disease Clinics of North America 14:2, pages 435-447.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.